Evidence map›Paper›PMID 38692712›Full record

Trial reportBMJ open2024

Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial.

Anne Holbrook, Sue Troyan, Victoria Telford, Yousery Koubaesh, Kristina Vidug, Lindsay Yoo, Jiawen Deng, Simran Lohit, Stephen Giilck, Amna Ahmed and 10 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02777047 (Coordination of Oral Anticoagulant Care at Hospital Discharge), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02777047 nacompletednot on this map

Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): A Pilot Randomized Trial

TypeinterventionalSponsorSt. Joseph's Healthcare HamiltonRan2020 to 2022Enrolled56ConditionsAnticoagulantsArmsAnticoagulation Coordinated Care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Anne HolbrookDivision of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada holbrook@mcmaster.ca.ORCID 0000-0002-3371-4187
Sue TroyanClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Victoria TelfordClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Yousery KoubaeshDivision of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Kristina VidugClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Lindsay YooClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Jiawen DengClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Simran LohitClinical Pharmacology Research, Research Institute of St. Joes Hamilton, Hamilton, Ontario, Canada.
Stephen GiilckDivision of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Amna AhmedDivision of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Marianne TalmanDivision of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Blair LeonardDivision of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Mohammad RefaeiDepartment of Medicine, Niagara Health System, St. Catharines, Ontario, Canada.
Jean-Eric TarrideDepartment of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.
Sam SchulmanDepartment of Medicine, Hamilton Health Sciences, Hamilton, Ontario, Canada.ORCID 0000-0002-8512-9043
James DouketisDivision of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Lehana ThabaneDepartment of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-0355-9734
Sylvia HylandInstitute for Safe Medication Practices Canada, North York, Ontario, Canada.
Joanne Man-Wai HoResearch Institute for Aging, University of Waterloo, Waterloo, Ontario, Canada.
Deborah SiegalDivision of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Population Health Research Institute · CAHamilton Health Sciences · CAMcMaster University · CANiagara Health System · CAGrand River Hospital · CAInstitute for Safe Medication Practices · USPrograms for Assessment of Technology in Health Research Institute · CAUniversity of Johannesburg · ZAUniversity of Ottawa · CAUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate whether a focused, expert medication management intervention is feasible and potentially effective in preventing anticoagulation-related adverse events for patients transitioning from hospital to home.

designRandomised, parallel design.

settingMedical wards at six hospital sites in southern Ontario, Canada.

participantsAdults 18 years of age or older being discharged to home on an oral anticoagulant (OAC) to be taken for at least 4 weeks.

interventionsClinical pharmacologist-led intervention, including a detailed discharge medication management plan, a circle of care handover and early postdischarge virtual check-up visits to 1 month with 3-month follow-up. The control group received the usual care. OUTCOMES MEASURES: Primary outcomes were study feasibility outcomes (recruitment, retention and cost per patient). Secondary outcomes included adverse anticoagulant safety events composite, quality of transitional care, quality of life, anticoagulant knowledge, satisfaction with care, problems with medications and health resource utilisation.

resultsExtensive periods of restriction of recruitment plus difficulties accessing patients at the time of discharge negatively impacted feasibility, especially cost per patient recruited. Of 845 patients screened, 167 were eligible and 56 were randomised. The mean age (±SD) was 71.2±12.5 years, 42.9% females, with two lost to follow-up. Intervention patients were more likely to rate their ability to manage their OAC as improved (17/27 (63.0%) vs 7/22 (31.8%), OR 3.6 (95% CI 1.1 to 12.0)) and their continuity of care as improved (21/27 (77.8%) vs 2/22 (9.1%), OR 35.0 (95% CI 6.3 to 194.2)). Fewer intervention patients were taking one or more inappropriate medications (7 (22.5%) vs 15 (60%), OR 0.19 (95% CI 0.06 to 0.62)).

conclusionThis pilot randomised controlled trial suggests that a transitional care intervention at hospital discharge for older adults taking OACs was well received and potentially effective for some surrogate outcomes, but overly costly to proceed to a definitive large trial. TRIAL REGISTRATION NUMBER: NCT02777047.

Indexed as

AnticoagulantsPatient DischargeAdministration, OralAgedAged, 80 and overContinuity of Patient CareFeasibility StudiesFemaleHumansMaleMiddle AgedOntarioPilot ProjectsQuality of LifeAnticoagulantsAnticoagulationCLINICAL PHARMACOLOGYHospitalization

Identifiers

PMID38692712
PMCPMC11086462
OpenAlexW4396544600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.